Literature DB >> 21458322

Increased prevalence of T(H)17 cells in the peripheral blood of patients with head and neck squamous cell carcinoma.

Chen Li1, Yifang Zhao, Wenfeng Zhang, Wei Zhang.   

Abstract

OBJECTIVE: This study was performed to determine whether T(H)17 cells are involved in the development and metastasis of head and neck squamous cell carcinomas (HNSCCs). STUDY
DESIGN: T(H)17 cells frequencies in 67 HNSCC patients and 21 healthy volunteers were examined by flow cytometric analysis. T(H)17 cell-related cytokines in serum (interleukin (IL) 17, transforming growth factor (TGF) β, and IL-6) were evaluated by using enzyme-linked immunosorbent assay.
RESULTS: It was discovered that the higher frequency of T(H)17 cells was in HNSCCs patients (1.0 ± 0.4%). The cell proportions and related cytokine concentrations were consistent with the tumor TNM stage. The IL-6 concentration showed positive correlation with the frequency of T(H)17 cells (r = 0.661) and IL-17 levels (r = 0.597). The TGF-β concentration showed a positive correlation with IL-17 (r = 0.626) but no relationship with T(H)17 cells (r = 0.431).
CONCLUSIONS: The present data suggested that T(H)17 cells may be involved in tumor growth and metastasis of HNSCCs. IL-6 may play an important role in T(H)17 cell differentiation and functions, and TGF-β may be related to IL-17 secretion but not to the differentiation of T(H)17 cells.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458322     DOI: 10.1016/j.tripleo.2010.11.032

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  10 in total

Review 1.  T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma.

Authors:  Daniele Maggioni; Lorenzo Pignataro; Werner Garavello
Journal:  Oncoimmunology       Date:  2017-05-04       Impact factor: 8.110

2.  Serum IL-17F combined with VEGF as potential diagnostic biomarkers for oral squamous cell carcinoma.

Authors:  Liang Ding; Er-Ling Hu; Yu-Jun Xu; Xiao-Feng Huang; Dong-Ya Zhang; Bing Li; Qin-Gang Hu; Yan-Hong Ni; Ya-Yi Hou
Journal:  Tumour Biol       Date:  2015-01-23

3.  Tumor-released survivin induces a type-2 t cell response and decreases cytotoxic T cell function, in vitro.

Authors:  Jessica M S Jutzy; Salma Khan; Malyn May Asuncion-Valenzuela; Terry-Ann M Milford; Kimberly J Payne; Nathan R Wall
Journal:  Cancer Microenviron       Date:  2012-02-10

Review 4.  Transforming growth factor-β signaling in head and neck squamous cell carcinoma: Insights into cellular responses.

Authors:  Xin Pang; Ya-Ling Tang; Xin-Hua Liang
Journal:  Oncol Lett       Date:  2018-08-17       Impact factor: 2.967

5.  Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.

Authors:  Tai Wei; Xin Cong; Xiang-Ting Wang; Xiao-Jian Xu; Sai-Nan Min; Peng Ye; Xin Peng; Li-Ling Wu; Guang-Yan Yu
Journal:  Oncotarget       Date:  2017-01-24

Review 6.  IL-6 in the Ecosystem of Head and Neck Cancer: Possible Therapeutic Perspectives.

Authors:  Michal Španko; Karolína Strnadová; Aleš Jan Pavlíček; Pavol Szabo; Ondřej Kodet; Jaroslav Valach; Barbora Dvořánková; Karel Smetana; Lukáš Lacina
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

Review 7.  The role of serum biomarkers in the diagnosis and prognosis of oral cancer: A systematic review.

Authors:  Ana Fernández-Olavarría; Regina Mosquera-Pérez; Rosa-María Díaz-Sánchez; Maria-Angeles Serrera-Figallo; José-Luis Gutiérrez-Pérez; Daniel Torres-Lagares
Journal:  J Clin Exp Dent       Date:  2016-04-01

8.  HNSCC subverts PBMCs to secrete soluble products that promote tumor cell proliferation.

Authors:  Marcell Costa de Medeiros; Rajat Banerjee; Min Liu; Giovana Anovazzi; Nisha J D'Silva; Carlos Rossa Junior
Journal:  Oncotarget       Date:  2017-06-15

9.  Salivary IL-17A, IL-17F, and TNF-α Are Associated with Disease Advancement in Patients with Oral and Oropharyngeal Cancer.

Authors:  Kinga Zielińska; Bożenna Karczmarek-Borowska; Konrad Kwaśniak; Justyna Czarnik-Kwaśniak; Aleksandra Ludwin; Bogumił Lewandowski; Jacek Tabarkiewicz
Journal:  J Immunol Res       Date:  2020-08-13       Impact factor: 4.818

Review 10.  A review on the advances and challenges of immunotherapy for head and neck cancer.

Authors:  Gang Cheng; Hui Dong; Chen Yang; Yang Liu; Yi Wu; Lifen Zhu; Xiangmin Tong; Shibing Wang
Journal:  Cancer Cell Int       Date:  2021-07-31       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.